arrow_back Trending Legislation
Share share

Boosting Funding and Focus for Pediatric Disease Research and New Therapies.

This law increases federal financial support for early-career scientists and doctors specializing in children's health research. The goal is to accelerate the discovery of new treatments for pediatric conditions, including cancer, rare diseases, and mental health issues. For citizens, this means a greater likelihood of faster access to innovative therapies for their children.
Key points
New Grants for Young Researchers: NIH will fund emerging talent to focus on pediatric research, including genetics and precision medicine.
Increased Focus on Key Diseases: Research priorities include childhood cancers, rare diseases (like sickle cell), and pediatric mental and behavioral health.
Better Research Coordination: A new Consortium is established to coordinate all NIH pediatric research programs, ensuring efficiency and identifying gaps.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Pediatricians Accelerate Childhood Therapies Act of 2023
Print number: S 2345
Sponsor: Sen. Ernst, Joni [R-IA]
Process start date: 2023-07-18
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Boosting Funding and Focus for Pediatric Disease Research and New Therapies.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 2345.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-07-18.

What are the main provisions?

Key points include:

  • New Grants for Young Researchers: NIH will fund emerging talent to focus on pediatric research, including genetics and precision medicine.
  • Increased Focus on Key Diseases: Research priorities include childhood cancers, rare diseases (like sickle cell), and pediatric mental and behavioral health.
  • Better Research Coordination: A new Consortium is established to coordinate all NIH pediatric research programs, ensuring efficiency and identifying gaps.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Ernst, Joni [R-IA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of S 2345

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health